相关实验视频
Updated: Jan 8, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
在1型糖尿病中,与贝叶斯算法建议相比,胰岛素注射调整的医生间和医生内变异性与贝叶斯算法建议相比
Alessandra Kobayati1,2, Michael A Tsoukas2,3, Natasha Garfield2,3
1Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, Canada.
Diabetologia
|December 15, 2025
概括
使用麦吉尔大学的决策支持系统 (DSS) 对1型糖尿病的自动胰岛素调整显示出与内分泌学家相似的结果. 这凸显了人工智能在糖尿病管理中的潜力,以及医生决策的主观性.
科学领域:
- 内分泌学 在内分泌学.
- 人工智能在医学中的应用
- 糖尿病管理 糖尿病管理
背景情况:
- 1型糖尿病需要精确的胰岛素管理,通常需要每天多次注射.
- 需要自动化胰岛素调整系统用于无监督使用,以改善患者的治疗结果.
- 当前的胰岛素调整方案可能是主观的,并且在临床医生之间有所不同.
研究的目的:
- 评估麦吉尔大学的决策支持系统 (DSS),一个贝叶斯算法,用于自动化胰岛素调整.
- 将算法的建议与内分泌学家对1型糖尿病管理的建议进行比较.
- 评估胰岛素调整决策中的内医变异性.
主要方法:
- 对13名加拿大内分泌学家进行了一项调查,使用了回顾性参与者数据.
- 医生根据每周 (A部分) 和每两周 (C部分) 的数据进行模拟胰岛素调整,并将其与麦吉尔DSS算法进行比较.
- 通过比较医生对相同数据集的建议 (B部分与A部分) 来评估医生内部的变异性.
主要成果:
- 算法和医生之间关于每周胰岛素调整方向的协议率不低于医生之间的协议,无论是prandial bolus还是基础胰岛素.
- 在算法和医生之间,完全不同意率是可比的.
- 医生表现出显著的内部变异性,只在66-67%的时间内同意他们自己之前的决定.
结论:
- 麦吉尔DSS算法向内分泌学家展示了可比的胰岛素调整方向.
- 该研究强调了自动化决策支持系统在糖尿病护理中的潜力.
- 显著的医生内部变异性突显了1型糖尿病胰岛素管理的主观性质.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
656
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
656
Dosage Regimen: Individualization
151
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
151
Insulin Formulations: Types and Delivery
605
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
605
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K

